Acute Crit Care.  2021 May;36(2):164-168. 10.4266/acc.2020.00269.

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child

• Choi IS
• Jeong HK
• Park HW
• Kim YS

• KMID: 2516265
• DOI: http://doi.org/10.4266/acc.2020.00269

Abstract

Pediatric cardiac tumors are rare. Among these, cardiac fibroma is the second most common. Its clinical manifestations depend on size and location of the tumor and include arrhythmia or obstruction to blood flow. Symptomatic cardiac fibroma is generally treated with surgical resection or cardiac transplantation. We present the case of a 12-year-old boy with a lethal ventricular arrhythmia induced by a remnant tumor that was previously partially resected. An implantable cardioverter defibrillator was inserted as the arrhythmia was resistant to medical treatment. He was discharged in stable condition with an implantable cardioverter defibrillator generator and followed up in the outpatient clinic.

Keyword

defibrillator; fibroma; implantable; tachycardia, ventricular

Figure

• 

  Figure 1. Chest radiograph showing cardiomegaly (cardiothoracic ratio, 0.55).

• 

  Figure 2. Two-dimensional echocardiogram in four-chamber view showing a mass in left ventricle anteroseptal wall (white arrow).

• 

  Figure 3. Chest computed tomography in sagittal view showing a mass in left ventricle anteroseptal wall (white arrows).

• 

  Figure 4. Electrocardiogram showing monomorphic ventricular tachycardia.

• 

  Figure 5. Chest radiograph showing placement of an implantable cardioverter defibrillator system.

Reference

1. Elderkin RA, Radford DJ. Primary cardiac tumours in a paediatric population. J Paediatr Child Health. 2002; 38:173–7.

2. Parmley LF, Salley RK, Williams JP, Head GB 3rd. The clinical spectrum of cardiac fibroma with diagnostic and surgical considerations: noninvasive imaging enhances management. Ann Thorac Surg. 1988; 45:455–65.

3. Bortolotti U, Maraglino G, Rubino M, Santini F, Mazzucco A, Milano A, et al. Surgical excision of intracardiac myxomas: a 20-year follow-up. Ann Thorac Surg. 1990; 49:449–53.

4. Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss & Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins;2016.

5. Mühler EG, Kienast W, Turniski-Harder V, von Bernuth G. Arrhythmias in infants and children with primary cardiac tumours. Eur Heart J. 1994; 15:915–21.

6. Cho JM, Danielson GK, Puga FJ, Dearani JA, McGregor CG, Tazelaar HD, et al. Surgical resection of ventricular cardiac fibromas: early and late results. Ann Thorac Surg. 2003; 76:1929–34.

7. Thøgersen AM, Helvind M, Jensen T, Andersen JH, Jacobsen JR, Chen X. Implantable cardioverter defibrillator in a 4-monthold infant with cardiac arrest associated with a vascular heart tumor. Pacing Clin Electrophysiol. 2001; 24:1699–700.

8. Chockalingam P, Clur SA, Wilde AA, Kuipers I, van Woensel J, Blom NA. Implantable cardioverter defibrillator as a bridge to recovery in an infant with cardiac rhabdomyoma. Eur J Pediatr. 2009; 168:863–6.

9. Park JK, Pollock ME. Use of an implantable cardioverter defibrillator in an eight-month-old infant with ventricular fibrillation arising from a myocardial fibroma. Pacing Clin Electrophysiol. 1999; 22(1 Pt 1):138–9.

10. Myers KA, Wong KK, Tipple M, Sanatani S. Benign cardiac tumours, malignant arrhythmias. Can J Cardiol. 2010; 26:e58–61.